BPIFC
BPI fold-containing family C protein
Also known as: BPIFC_HUMAN, BPIL2, dJ149A16.7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NFQ6
- Gene
- BPIFC
- Ensembl
- ENSG00000184459
- Chromosome
- 22
- Canonical length
- 507 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Predicted to enable lipopolysaccharide binding activity and phospholipid binding activity. Predicted to be involved in defense response to Gram-negative bacterium and innate immune response. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
507 residues, UniProt reviewed canonical sequence.
>Q8NFQ6|BPIFC
1 MCTKTIPVLW GCFLLWNLYV SSSQTIYPGI KARITQRALD YGVQAGMKMI EQMLKEKKLP
61 DLSGSESLEF LKVDYVNYNF SNIKISAFSF PNTSLAFVPG VGIKALTNHG TANISTDWGF
121 ESPLFQDTGG ADLFLSGVYF TGIIILTRND FGHPTLKLQD CYAQLSHAHV SFSGELSVLY
181 NSFAEPMEKP ILKNLNEMLC PIIASEVKAL NANLSTLEVL TKIDNYTLLD YSLISSPEIT
241 ENYLDLNLKG VFYPLENLTD PPFSPVPFVL PERSNSMLYI GIAEYFFKSA SFAHFTAGVF
301 NVTLSTEEIS NHFVQNSQGL GNVLSRIAEI YILSQPFMVR IMATEPPIIN LQPGNFTLDI
361 PASIMMLTQP KNSTVETIVS MDFVASTSVG LVILGQRLVC SLSLNRFRLA LPESNRSNIE
421 VLRFENILSS ILHFGVLPLA NAKLQQGFPL SNPHKFLFVN SDIEVLEGFL LISTDLKYET
481 SSKQQPSFHV WEGLNLISRQ WRGKSAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BPIFC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- skin: 43 nTPM
- breast: 2.2 nTPM
- testis: 1.5 nTPM
- cervix: 0.8 nTPM
- tonsil: 0.6 nTPM
- vagina: 0.4 nTPM
Single-cell type
- early spermatids: 24 nCPM
- late primary spermatocytes: 18 nCPM
- late spermatids: 13 nCPM
- suprabasal keratinocytes: 10 nCPM
- retinal horizontal cells: 4 nCPM
- retinal ganglion cells: 3.9 nCPM
Immune cell
- basophil: 1.5 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.5 nTPM
- hypothalamus: 0.4 nTPM
- amygdala: 0.3 nTPM
- basal ganglia: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.89
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Lipid-binding serum glycoprotein, C-terminal
- Lipid-binding serum glycoprotein, N-terminal
- Bactericidal permeability-increasing protein, alpha/beta domain superfamily
- Lipid-binding serum glycoprotein, conserved site
- Lipid binding protein BPI/LBP
- BPI/LBP/Plunc family
- LBP / BPI / CETP family, N-terminal domain
- LBP / BPI / CETP family, C-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BPIFC as an antibody target. Whether an autoantibody or antibody against BPIFC could matter depends on whether native BPIFC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BPIFC is annotated as secreted, so native BPIFC circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label BPIFC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...